Daniel S Goldberger
CIK 1382042 · Chief Executive Officer · last filed 2026-06-12
Daniel S Goldberger is a Chief Executive Officer who has filed 65 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing shows the insider sold $544.0K of ECOR on Jun 12, 2026. Across all open-market trades the lifetime net is +$214.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.78M
6
65
$214.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ECOR | Chief Executive Officer | 211,471 | $6.09 | $1.29M | -$45.6K | 28 | 2026-06-12 |
| KRMD | Director | 120,334 | $4.01 | $482.5K | $7.6K | 13 | 2022-04-04 |
| MLSS | President and CEO | 10,000 | $0.43 | $4.3K | $11.4K | 3 | 2017-08-21 |
| XTNT | Chief Executive Officer | 18,502 | $0.43 | $7.9K | $20.1K | 3 | 2016-11-25 |
| Xtant Medical Holdings, Inc. (BONE) Delisted | President and CEO | 10,010 | — | — | $53.6K | 5 | 2013-11-15 |
| Xcorporeal, Inc. (XCR) Delisted | Chief Executive Officer | 110,000 | — | — | $167.0K | 3 | 2008-09-09 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | ECOR | Sell (S) | −80,000 | -$544.0K | EDGAR |
| 2026-05-14 | ECOR | Notice (144) | −45,000 | -$291.6K | EDGAR |
| 2026-05-05 | ECOR | Notice (144) | −25,000 | -$168.0K | EDGAR |
| 2026-04-23 | ECOR | Notice (144) | −10,000 | -$61.3K | EDGAR |
| 2026-04-14 | ECOR | Sell (S) | −16,072 | -$96.8K | EDGAR |
| 2026-01-28 | ECOR | Grant (A) | +46,375 | $152.2K | EDGAR |
| 2025-12-03 | ECOR | Buy (P) | +1,000 | $4.8K | EDGAR |
| 2025-08-12 | ECOR | Buy (P) | +1,000 | $4.2K | EDGAR |
| 2025-03-18 | ECOR | Buy (P) | +1,000 | $8.6K | EDGAR |
| 2025-01-21 | ECOR | Grant (A) | +40,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.